Last month a team of doctors and scientists made the case to regulators at the Food and Drug Administration (FDA) to consider approving anti-ageing drugs as a new pharmaceutical class. Such a designation would treat ageing as disease rather than a natural process, potentially opening the door to government funding…
Now you can get the top stories from Gizmodo delivered to your inbox. Enter your email below.
By subscribing you agree to our Terms of Use and Privacy Policy.